PAPER Leuchter MK, Oughli HA, Durbin KA, Jackson NJ, Elashoff D, Chang TS, Corlier J, Ngo D, Matthews C, Wong D, Fogel BL, Bitan G, Leuchter AF, Vossel K, Suthana N

Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design.

Alzheimers Dement (N Y). 2025;11(1):e70043. Epub 2025 Mar 10 PubMed.

PAPER Liu GS, Song Y, Yan JS, Chai YJ, Zhao YF, Ma H

Identification of enterotype for patients with Alzheimer's disease.

J Transl Med. 2025 Mar 10;23(1):299. PubMed.

PAPER Lv L, Zhang H, Tan J, Wang C

Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson's disease.

Cell Commun Signal. 2025 Mar 10;23(1):129. PubMed.

PAPER Cai Y, Kanyo J, Wilson R, Bathla S, Cardozo PL, Tong L, Qin S, Fuentes LA, Pinheiro-de-Sousa I, Huynh T, Sun L, Mansuri MS, Tian Z, Gan HR, Braker A, Trinh HK, Huttner A, Lam TT, Petsalaki E, Brennand KJ, Nairn AC, Grutzendler J

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease.

Nat Aging. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Bian X, Guo Q, Yau LF, Yang L, Wang X, Zhao S, Wu S, Qin X, Jiang ZH, Li C

Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics.

Nat Commun. 2025 Mar 10;16(1):2368. PubMed.

PAPER Dahiya M, Yadav M, Goyal C, Kumar A

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies.

Inflammopharmacology. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Qaisar R, Karim A, Iqbal MS, Alkahtani SA, Ahmad F

Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer's diseases.

Acta Neurol Belg. 2025 Mar 11; Epub 2025 Mar 11 PubMed.

PAPER Xiao Y, Zhang M, Lu N

Fluorescent Fingerprint Identification of Protein Structural Changes and Disease-Specific Amyloid Beta Aggregates Based on a Single-Nanozyme Sensor Array.

Anal Chem. 2025 Mar 11;97(9):4978-4986. Epub 2025 Feb 25 PubMed.

PAPER Pollock JM, Yew CH, Tripathi A

Utilizing Functionalized Dual-Microbead Interfaces for Measurements of Amyloid-beta (1-42) with Femtomolar Sensitivity.

Langmuir. 2025 Mar 11;41(9):5870-5876. Epub 2025 Feb 24 PubMed.

PAPER Liu J, Chen L, Zhang ZL, Wen W, Zhang X, Wu Z, Wang S

Nano-Collision Electrochemistry for Real-Time Monitoring of Amyloid-β Oligomerization and Rapid Screening of Degrading Drugs.

Anal Chem. 2025 Mar 11;97(9):4898-4905. Epub 2025 Feb 24 PubMed.

PAPER Wu Y, Xu R, Gasevic D, Yang Z, Yu P, Wen B, Liu Y, Zhou G, Zhang Y, Song J, Liu H, Li S, Guo Y

UK Biobank data demonstrate long-term exposure to floods is a risk factor for incident dementia.

Commun Med (Lond). 2025 Mar 10;5(1):71. PubMed.

PAPER Tang M, Rong D, Gao X, Lu G, Tang H, Wang P, Shao NY, Xia D, Feng XH, He WF, Chen W, Lu JH, Liu W, Shen HM

A positive feedback loop between SMAD3 and PINK1 in regulation of mitophagy.

Cell Discov. 2025 Mar 11;11(1):22. PubMed.

Robert Mach on A positron emission tomography tracer for the imaging of oxidative stress in the central nervous system.

COMMENT I congratulate the authors for trying to develop an alternative strategy to imaging reactive oxygen and reactive nitrogen species (ROS/RNS) in vivo with PET. Our group developed the radiotracer, [18F]ROStrace, and we have conducted PET imaging studies to

PAPER Gallagher E, Li S, Lee H, Xu H, Lee VMY, Mach RH, McManus MJ

Noninvasive Detection of Oxidative Stress in a Mouse Model of 4R Tauopathy via Positron Emission Tomography with [18F]ROStrace

Int. J. Mol. Sci. 2025 . International Journal of Molecular Sciences

Risvodetinib

THERAPEUTICS Inhibikase Therapeutics, Inc. IkT-148009 Small Molecule alpha-synuclein Other Between February 2021 and January 2023, Inhibikase ran a Phase 1 single- and multiple-ascending-dose trial. The study enrolled 108 participants, and tested nine single doses fro